Androgen receptor-targeting agents, particularly enzalutamide, show promise in enhancing prostate cancer diagnostic and therapeutic strategies by modulating prostate-specific membrane antigen (PSMA). A retrospective clinical cohort study investigated 9 men with metastatic castration-resistant prostate cancer on enzalutamide. PSMA PET/CT scans were obtained before and after enzalutamide initiation to assess PSMA expression changes.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
March 2025
A field campaign in the Vallunden lagoon in the Van Mijenfjorden on Spitsbergen was conducted to gather data on sea ice restoration by artificial flooding. Sea ice thickening was initiated by pumping sea water from below the first-year sea ice onto the surface without removing the covering snow layer. Part of the data was collected by four thermistor strings, two radiation sensors, and one anemometer.
View Article and Find Full Text PDFUpregulation of prostate-specific membrane antigen (PSMA) in neovasculature has been described in glioblastoma multiforme (GBM), whereas vasculature in nonaffected brain shows hardly any expression of PSMA. It is unclear whether PSMA-targeting tracer uptake on PET is based on PSMA-specific binding to neovasculature or aspecific uptake in tumor. Here, we quantified uptake of various PSMA-targeting tracers in GBM and correlated this with PSMA expression in tumor biopsy samples from the same patients.
View Article and Find Full Text PDF